Arash Haghikia

3.5k total citations · 2 hit papers
57 papers, 1.6k citations indexed

About

Arash Haghikia is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Arash Haghikia has authored 57 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Cardiology and Cardiovascular Medicine and 16 papers in Physiology. Recurrent topics in Arash Haghikia's work include Gut microbiota and health (8 papers), Nitric Oxide and Endothelin Effects (7 papers) and Cardiac Imaging and Diagnostics (7 papers). Arash Haghikia is often cited by papers focused on Gut microbiota and health (8 papers), Nitric Oxide and Endothelin Effects (7 papers) and Cardiac Imaging and Diagnostics (7 papers). Arash Haghikia collaborates with scholars based in Germany, United States and Switzerland. Arash Haghikia's co-authors include Ulf Landmesser, Denise Hilfiker‐Kleiner, Britta Stapel, Aiden Haghikia, Xinmin S. Li, Stanley L. Hazen, Melanie Ricke‐Hoch, Johann Bauersachs, David M. Leistner and Dimitrios Tsikas and has published in prestigious journals such as Nature Medicine, Journal of Neuroscience and Blood.

In The Last Decade

Arash Haghikia

54 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The artificial sweetener erythritol and cardiovascular event risk

2023 115 citations Marco Witkowski, Ina Nemet et al. Nature Medicine profile →
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk

2024 59 citations Marc Ferrell, Zeneng Wang et al. Nature Medicine profile →

Peers

Countries citing papers authored by Arash Haghikia

Since Specialization

Citations

This map shows the geographic impact of Arash Haghikia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arash Haghikia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arash Haghikia more than expected).

Fields of papers citing papers by Arash Haghikia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arash Haghikia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arash Haghikia. The network helps show where Arash Haghikia may publish in the future.

Co-authorship network of co-authors of Arash Haghikia

This figure shows the co-authorship network connecting the top 25 collaborators of Arash Haghikia. A scholar is included among the top collaborators of Arash Haghikia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arash Haghikia. Arash Haghikia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk breakdown → 2024 ·Nature Medicine ·Marc Ferrell, Zeneng Wang, James T. Anderson, Xinmin S. Li, Marco Witkowski, Joseph A. DiDonato, James R. Hilser, Jaana Hartiala, Arash Haghikia, Tomáš Čajka, Oliver Fiehn, Naseer Sangwan, Ilja Demuth, Maximilian König, Elisabeth Steinhagen‐Thiessen, Ulf Landmesser, W.H. Wilson Tang, Hooman Allayee, Stanley L. Hazen	59
2	Effects of Oral Butyrate on Blood Pressure in Patients With Hypertension: A Randomized, Placebo-Controlled Trial 2024 ·Hypertension ·Barbara J. H. Verhaar, (unknown), Koen Wortelboer, Elena Rampanelli, Johannes H.M. Levels, Didier Collard, (unknown), Vanasa Nageswaran, Arash Haghikia, Ulf Landmesser, Xinmin S. Li, Joseph A. DiDonato, Stanley L. Hazen, Ingrid M. Garrelds, A.H. Jan Danser, Bert‐Jan H. van den Born, (unknown), Majon Muller	19
3	Full-Moon Coronary Calcification as Detected With Computed Tomography Angiography in Chronic Total Occlusion Percutaneous Coronary Intervention 2024 ·The American Journal of Cardiology ·(unknown), Gerald S. Werner, Salvatore De Rosa, Daniele Torella, David M. Leistner, Patrick T. Siegrist, Arash Haghikia, Carsten Skurk, (unknown), Ulf Landmesser, Youssef S. Abdelwahed	12
4	Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19 2023 ·International Journal of Molecular Sciences ·(unknown), Kai Jakobs, (unknown), Julian Friebel, (unknown), (unknown), Ulf Landmesser, Arash Haghikia, Nicolle Kränkel, Ursula Rauch	7
5	The artificial sweetener erythritol and cardiovascular event risk breakdown → 2023 ·Nature Medicine ·Marco Witkowski, Ina Nemet, Hassan S. Alamri, Jennifer Wilcox, Nilaksh Gupta, Nisreen Nimer, Arash Haghikia, Xinmin S. Li, Yuping Wu, Prasenjit Prasad Saha, Ilja Demuth, Maximilian König, Elisabeth Steinhagen‐Thiessen, Tomáš Čajka, Oliver Fiehn, Ulf Landmesser, W.H. Wilson Tang, Stanley L. Hazen	115
6	The artificial sweetener erythritol and cardiovascular event risk 2023 ·Yearbook of pediatric endocrinology ·Marco Witkowski, Ina Nemet, Hassan S. Alamri, J. R. Wilcox, Noopur Gupta, Nisreen Nimer, Arash Haghikia, (unknown), (unknown), (unknown), Ilja Demuth, Markus König, Elisabeth Steinhagen‐Thiessen, Tomáš Čajka, Oliver Fiehn, Ulf Landmesser, (unknown), (unknown)	1
7	Prognostic Value of Gut Microbe-Generated Metabolite Phenylacetylglutamine in Patients with Heart Failure 2023 ·European Journal of Heart Failure ·W.H. Wilson Tang, Ina Nemet, Xinmin S. Li, Yuping Wu, Arash Haghikia, Marco Witkowski, Robert Koeth, Ilja Demuth, Maximilian König, Elisabeth Steinhagen‐Thiessen, Fredrik Bäckhed, Michael A. Fischbach, Arjun Deb, Ulf Landmesser, Stanley L. Hazen	18
8	Large-scale microRNA functional high-throughput screening identifies miR-515-3p and miR-519e-3p as inducers of human cardiomyocyte proliferation 2023 ·iScience ·(unknown), Katina Lazarow, (unknown), Praphulla Chandra Shukla, Vanasa Nageswaran, Héctor Giral, Adelheid Kratzer, Lennart Opitz, Felix B. Engel, Arash Haghikia, Sarah Costantino, Francesco Paneni, Jens Peter von Kries, Katrin Streckfuß‐Bömeke, Ulf Landmesser, Philipp Jakob	2
9	Low-density lipoprotein cholesterol goal attainment in patients with clinical evidence of familial hypercholesterolemia and elevated Lp(a) 2022 ·Lipids in Health and Disease ·(unknown), Ilja Demuth, Ulf Landmesser, Arash Haghikia, Maximilian König, Elisabeth Steinhagen‐Thiessen	2
10	Coexistence of calcified- and lipid-containing plaque components and their association with incidental rupture points in acute coronary syndrome-causing culprit lesions: results from the prospective OPTICO-ACS study 2021 ·European Heart Journal - Cardiovascular Imaging ·Youssef S. Abdelwahed, (unknown), (unknown), (unknown), (unknown), Barbara E. Stähli, Himanshu Rai, Matthias Riedel, Carsten Skurk, Ursula Rauch‐Kröhnert, Arash Haghikia, David Sinning, Henryk Dreger, Fabian Knebel, Tobias Daniel Trippel, (unknown), Jens Klotsche, Michael Joner, Ulf Landmesser, David M. Leistner	6
11	Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis 2021 ·Cardiovascular Research ·Marco Witkowski, Mario Witkowski, Julian Friebel, Jennifer A. Buffa, Xinmin S. Li, Zeneng Wang, Naseer Sangwan, Lin Li, Joseph A. DiDonato, Caroline Tizian, Arash Haghikia, Daniel Kirchhofer, François Mach, Lorenz Räber, Christian M. Matter, W.H. Wilson Tang, Ulf Landmesser, Thomas F. Lüscher, Ursula Rauch, Stanley L. Hazen	72
12	Feasibility and diagnostic reliability of quantitative flow ratio in the assessment of non-culprit lesions in acute coronary syndrome 2021 ·International journal of cardiac imaging ·(unknown), (unknown), Youssef S. Abdelwahed, Jens Klotsche, (unknown), Julia Steiner, Arash Haghikia, Ulf Landmesser, Barbara E. Stähli, David M. Leistner	15
13	Impact of the Gut Microbiota on Atorvastatin Mediated Effects on Blood Lipids 2020 ·Journal of Clinical Medicine ·Friederike Zimmermann, Johann Roessler, David Schmidt, Andrzej Jasina, P. A. Schumann, Martina Gast, Wolfgang Poller, David M. Leistner, Héctor Giral, Nicolle Kränkel, Adelheid Kratzer, Sven Schuchardt, Markus M. Heimesaat, Ulf Landmesser, Arash Haghikia	21
14	Impact of real-time angiographic co-registered optical coherence tomography on percutaneous coronary intervention: the OPTICO-integration II trial 2020 ·Clinical Research in Cardiology ·(unknown), Felix Böhm, (unknown), Matthias Riedel, Youssef S. Abdelwahed, Jens Klotsche, Julia Steiner, (unknown), Carsten Skurk, Hans‐Christian Mochmann, Alexander Lauten, Georg Fröhlich, Ursula Rauch‐Kröhnert, Arash Haghikia, David Sinning, Barbara E. Stähli, Ulf Landmesser, David M. Leistner	11
15	Association of left ventricular end‐diastolic pressure with mortality in patients undergoing percutaneous coronary intervention for acute coronary syndromes 2020 ·Catheterization and Cardiovascular Interventions ·David M. Leistner, (unknown), (unknown), Julia Steiner, Youssef S. Abdelwahed, Patrick T. Siegrist, Matthias Schindler, Carsten Skurk, Arash Haghikia, David Sinning, Matthias Riedel, Ulf Landmesser, Barbara E. Stähli	12
16	Effect of inclisiran, the siRNA against PCSK9, on platelets, immune cells and immunological biomarkers - a pre-specified analysis from ORION-1. 2020 ·Cardiovascular Research ·Ulf Landmesser, Arash Haghikia, LA Leiter, (unknown), David Kallend, P. Wijngaard, Robert M. Stoekenbroek, (unknown), Kausik K. Ray	16
17	In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial roles 2019 ·Cardiovascular Research ·Melanie Ricke‐Hoch, Martijn F. Hoes, Tobias J. Pfeffer, (unknown), (unknown), (unknown), Nils Bömer, Michaela Scherr, Britta Stapel, (unknown), Yulia Kiyan, Christine S. Falk, Arash Haghikia, Ofer Binah, Zoltàn Arany, Thomas Thum, Johann Bauersachs, Peter van der Meer, Denise Hilfiker‐Kleiner	27
18	Elevated levels of miR-181c and miR-633 in the CSF of patients with MS 2019 ·Neurology Neuroimmunology & Neuroinflammation ·(unknown), Arash Haghikia, Claudia Bang, Kristian Scherf, Angelika Pfanne, Alexander Duscha, (unknown), Barbara Gisevius, Ralf Gold, Thomas Thum, Aiden Haghikia	17
19	Imaging of chemokine receptor CXCR4 expression in culprit and nonculprit coronary atherosclerotic plaque using motion-corrected [68Ga]pentixafor PET/CT 2018 ·European Journal of Nuclear Medicine and Molecular Imaging ·Thorsten Derlin, Daniel Sedding, Jochen Dutzmann, Arash Haghikia, Tobias König, L. Christian Napp, Christian Schütze, (unknown), Hans‐Jürgen Wester, Saskia Kropf, James T. Thackeray, Jens P. Bankstahl, Lilli Geworski, Tobias L. Roß, Johann Bauersachs, Frank M. Bengel	60
20	Simultaneous GC-ECNICI-MS measurement of nitrite, nitrate and creatinine in human urine and plasma in clinical settings 2016 ·Journal of Chromatography B ·Erik Hanff, (unknown), Arslan Arinc Kayacelebi, (unknown), (unknown), (unknown), Arash Haghikia, Udo Bavendiek, (unknown), Thomas Lücke, Norbert Maassen, Dimitrios Tsikas	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact